|  |  | 

India Top Headlines

Vaccination: There are still no warnings on the detection of adverse events, reporting drastic falls | India News


NEW DELHI: Adverse event reporting after Covid-19 vaccination dropped significantly to nearly 25% or a quarter of what was reported in early March, even as vaccines peaked in mid-March and mid-April after the government extended coverage to the population over 45 years of age.
While the government has yet to issue a warning on identifying, managing, and treating serious and serious adverse events after vaccination (AEFI), experts have raised concerns about the significant drop in AEFI.
“There is a drastic decrease in AEFI reporting. This may be of concern because it makes further research on the effectiveness and side effects of the Covid vaccine difficult,” said a senior official. Official sources said the notice has been finalized and is expected by the end of this week.
The AEFI parameters remain unchanged and most are classified as minor. With early apprehensions about vaccines diminishing, some of the anxiety-related reactions have also decreased. However, the absence of guidelines that were due at least three weeks ago has made it difficult to follow up and respond to the AEFI.
The national AEFI committee submitted a draft notice to the Ministry of Health in mid-April along with a detailed report based on the evaluation of around 498 ‘serious and severe’ AEFI samples, such as rare blood clots that were reported after that beneficiaries received Covid injections. Some of these events were reported in countries, mainly in the West, after the administration of the Covid vaccine from AstraZeneca-Oxford University.
“Although the assessment indicates (points to) racial differences and that the incidence of thrombocytopenia (low platelet count) after vaccination is uncommon in India, the reporting and further investigation of AEFIs in India remains crucial due to the large volume of vaccinations. It is important to assess the AEFI to rule out risk and reiterate the preliminary findings of the evaluation of the initial 498 AEFI, “said a member of the AEFI committee.
Officials say the lack of AEFI reports also poses a potential risk. Since 90% of AEFIs are minor, recipients may not report much of them as people are gaining confidence in the safety of vaccines.

Times of India